There are 2934 resources available
5435 - TCR-beta repertoire convergence and evenness are associated with response to immune checkpoint inhibitors
Presenter: Philip Jermann
Session: Poster Discussion 1 – Translational research
Resources:
Abstract
5443 - Harmonization study of Tumour Mutational Burden determination in Non-Small-Cell Lung Cancer (NSCLC)
Presenter: Eva M Garrido-Martin
Session: Poster Discussion 1 – Translational research
Resources:
Abstract
3307 - Switch Maintenance Gemcitabine After First Line Chemotherapy In Patients With Malignant Mesothelioma; A Multicenter Open Label Phase II Trial (NVALT19)
Presenter: Sjaak Burgers
Session: Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies - Invited Discussant 1740PD, 1741PD, 1742PD and LBA92
Presenter: Giuseppe Lo Russo
Session: Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast
Presentation by expert
Presenter: Maria De Santis
Session: Specificity of upper tract urothelial carcinoma biology and management
Resources:
Slides
Discussion led by Chair
Presenter: Kjell Oeberg
Session: Early diagnosis of neuroendocrine tumours (NETs): Increasing awareness and optimising diagnostic work up
Resources:
Slides
Webcast
6093 - BRCA1 expression level as prognostic factor for recurrence in resected NSCLC with adjuvant chemotherapy. SCAT Trial
Presenter: Bartomeu Massuti
Session: Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
5626 - JIPANG study: Randomized Phase III Study of pemetrexed/cisplatin (PEM/Cis) versus vinorelbine /cisplatin (VNR/Cis) for completely resected p-stage II-IIIA non-squamous non-small cell lung cancer (Ns-NSCLC): Outcomes based on EGFR mutation status
Presenter: Masahiro Tsuboi
Session: Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
2782 - Efficacy evaluation of concurrent nivolumab addition to a first-line, concurrent chemo-radiotherapy regimen in unresectable locally advanced NSCLC – Results from the European Thoracic Oncology Platform (ETOP 6-14) NICOLAS phase II trial.
Presenter: Solange Peters
Session: Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
1634 - Phase III Study Comparing Second- and Third-Generation Regimens With Concurrent Thoracic Radiotherapy in Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: 10-year follow-up of West Japan Thoracic Oncology Group WJTOG0105
Presenter: Yoshitaka Zenke
Session: Poster Discussion - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract